Skip to main content
Journal of Clinical Oncology logoLink to Journal of Clinical Oncology
. 2021 Apr 1;39(11):1309. doi: 10.1200/JCO.21.00642

Erratum

PMCID: PMC8462574  PMID: 33826867

The April 10, 2020, article by Ball et al entitled “Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and Intervention” (J Clin Oncol 10.1200/JCO.19.02263) was published with errors.

In the legend for Figure 4, “Oldest Quartile Patients (age < 60 years)” should have read “Oldest Quartile Patients (age > 60 years).”

In Table 2:

  • In the “Nonsense/frameshift” row, GR (IQR) was listed as “0.38 (0.28-.056).” It should have been “0.38 (0.28-0.56).”

  • In the “Complete deletion” row, GR (IQR) was listed as “0.30 (0.025-0.034).” It should have been “0.30 (0.25-0.34).”

  • In the “β (n = 84)” row, GR (IQR) was listed as “0.37 (0.25-0.059).” It should have been “0.37 (0.25-0.59).”

  • In the “Elongin C binding (n = 37)” row, GR (IQR) was listed as “0.40 (0.22-0.054).” It should have been “0.40 (0.22-0.54).”

  • In the “Nuclear export (n = 28)” row, GR (IQR) was listed as “0.39 (0.25-0.063).” It should have been “0.39 (0.25-0.63).”

This has been corrected as of March 17, 2021. The authors apologize for the errors.


Articles from Journal of Clinical Oncology are provided here courtesy of American Society of Clinical Oncology

RESOURCES